New evolution-busting drug overcomes resistance in aggressive breast cancers 05 Oct 2019 A new type of drug that blocks one of cancer’s key evolutionary escape routes from chemotherapy could be used to treat aggressive breast cancers, a new study has shown. Find out more Show/Hide
ICR calls for wider gene testing in ovarian cancer after approval of olaparib earlier in treatment for women with BRCA mutations 26 Jul 2019 The ICR responds to the approval by NHS regulators NICE for the use of targeted cancer drug olaparib earlier in the course of treatment for women with late-stage ovarian cancer and other gynaecological cancers who have BRCA gene mutations. Find out more Show/Hide
New ‘Trojan horse’ cancer treatment shows early promise in multiple tumour types 07 Feb 2019 A brand new type of cancer drug that acts as a ‘Trojan horse’ to get inside tumour cells has shown promise in patients with six different cancer types. Find out more Show/Hide
New blood test detects early resistance to BRCA-targeting drugs for breast and ovarian cancer 02 Nov 2017